CM
AGN

Crestline Management’s Allergan plc AGN Stock Holding History

Crestline Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-20,000
Closed -$3.35M – 119
2019
Q2 		$3.35M Buy
+20,000
New +$2.77M 0.45% 35
2018
Q3 		– Sell
-32,635
Closed -$5.44M – 269
2018
Q2 		$5.44M Buy
32,635
+4,364
+15% +$701K 0.57% 14
2018
Q1 		$4.76M Sell
28,271
-659
-2% -$111K 0.59% 12
2017
Q4 		$4.73M Buy
+28,930
New +$5.19M 0.48% 15

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Crestline Management's AGN Position: Q3 2019 in Review

Crestline Management sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 20,000 shares — an estimated $3.35M sold.

Crestline Management first reported a position in AGN in Q4 2017 and held it in 4 quarters. The position peaked at $5.44M in Q2 2018. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Crestline Management reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Crestline Management sold 20,000 Allergan plc shares in Q3 2019, an estimated $3.35M.
  • Crestline Management first reported a position in Allergan plc in Q4 2017 and held it in 4 quarters.
  • Crestline Management's Allergan plc position peaked at $5.44M in Q2 2018.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Crestline Management's 13F filing for Q3 2019, filed 13 Nov 2019.